Benzinga’s Top Pre-Market Gainers (BVF, PCS, MYL, ESRX, IPXL)

Biovail Corporation (NYSE: BVF) increased 2.69% to $14.90 in the pre-market session. Biovail Corporation reported today a fourth-quarter net income of $73 million, or $0.46 per share, from $120.4 million, or $0.76 per share, in the year-ago period. Revenue increased 33% to $241.1 million for the quarter. Analysts expected Biovail to earn $0.42 per share on revenue of $224.2 million. BVF closed at $14.51 in the last trading session.

MetroPCS Communications, Inc. (NYSE: PCS) increased 5.45% to $6.58 in the pre-market session. MetroPCS Communications reported today a fourth-quarter earnings of $33 million, or $0.09 per share, as compared to $15 million, or $0.04 per share, in the year-earlier quarter. Revenue totaled $930 million, as compared to $724 million for the same quarter last year. The 52-week trading range for PCS is $5.52 - $18.98. In the last six months, PCS has declined over 22%.

Mylan Inc. (NASDAQ: MYL) climbed 1.96% to $19.80 in the pre-market session. Mylan Laboratories reported today a fourth-quarter net profit of $4.1 million, or $0.01 per share, from a loss of $54.6 million, or $0.18 per share, for the same quarter last year. In the previous trading session, MYL closed at $19.42. Mylan has surged over 54% in the last year.

Express Scripts, Inc. (NASDAQ: ESRX) jumped 9.12% to $95.75 in the pre-market session after Express Scripts announced yesterday that for fiscal 2010, it expects to achieve adjusted earnings per share in the range of $4.80 - $5.00. The 52-week trading range for ESRX is $42.75 - $93.00. Express Scripts closed at $87.75 in the last trading session.

Impax Laboratories, Inc. (NASDAQ: IPXL) moved up 7.72% to $16.05 in the pre-market session. Impax Laboratories reported today a fourth quarter total revenue of $176.1 million, up $131.4 million for the same quarter last year. The 52-week trading range for IPXL is $4.00 - $14.92. Impax Laboratories closed at $14.90 in the previous trading session.